Participation of leukotriene C(4) in the regulation of suicidal erythrocyte death.
Eryptosis, the suicidal death of erythrocytes, is characterized by cell shrinkage and cell membrane scrambling with phosphatidylserine exposure at the erythrocyte surface. Eryptosis is triggered by increase in cytosolic Ca(2+) concentration upon energy depletion. The present study explored the involvement of leukotrienes. Western blotting was employed to detect the cysteinyl-leukotriene receptor cysLT1, competitive immune assay to determine leukotriene release from erythrocytes, Fluo3 fluorescence to estimate cytosolic Ca(2+) concentration, forward scatter to analyse cell volume and annexin V-binding to disclose phosphatidylserine exposure. As a result, erythrocytes expressed the leukotriene receptor CysLT1. Glucose depletion (24 hours) significantly increased the formation of the cysteinyl-leukotrienes C(4)/D(4)/E(4). Leukotriene C(4) (10 nM) increased Ca(2+) entry, decreased forward scatter, activated caspases 3 and 8, and stimulated annexin V-binding. Glucose depletion similarly increased annexin V-binding, an effect significantly blunted in the presence of the leukotriene receptor antagonist cinalukast (1 microM) or the 5-lipoxygenase inhibitor BW B70C (1 microM). In conclusion, upon energy depletion erythrocytes form leukotrienes, which in turn activate cation channels, leading to Ca(2+) entry, cell shrinkage and cell membrane scrambling. Cysteinyl-leukotrienes thus participate in the signaling of eryptosis during energy depletion.
Foller
M
M
Department of Physiology, University of Tubingen, Germany.
Mahmud
H
H
Gu
S
S
Wang
K
K
Floride
E
E
Kucherenko
Y
Y
Luik
S
S
Laufer
S
S
Lang
F
F
D015153:Blotting, Western; D002118:Calcium / Q000378:metabolism; D053148:Caspase 3 / Q000378:metabolism; D053181:Caspase 8 / Q000378:metabolism; D018929:Cell Culture Techniques; D016923:Cell Death / Q000187:drug effects; D048429:Cell Size / Q000187:drug effects; D002478:Cells, Cultured; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000378:metabolism; D004912:Erythrocytes / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D005947:Glucose / Q000172:deficiency; D006801:Humans; D006918:Hydroxyurea / Q000031:analogs & derivatives / Q000494:pharmacology; D017997:Leukotriene C4 / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*; D018613:Microscopy, Confocal; D010718:Phosphatidylserines / Q000494:pharmacology; D018077:Receptors, Leukotriene / Q000096:biosynthesis*; D013844:Thiazoles / Q000494:pharmacology
D010718:Phosphatidylserines; D018077:Receptors, Leukotriene; D013844:Thiazoles; C080871:BW B70C; D017997:Leukotriene C4; C071436:cinalukast; D053148:Caspase 3; D053181:Caspase 8; D005947:Glucose; C083169:leukotriene D4 receptor; D002118:Calcium; D006918:Hydroxyurea